Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Asset disposition
Quarterly results
|
|
ProPhase Labs, Inc. (PRPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/06/2023 |
4
| Morse Robert A. Jr. (CFO) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 50,000 options to buy
@ $9, valued at
$450k
|
|
| 04/05/2023 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Gifted 50,000 shares
@ $0
Gifted 50,000 shares
@ $0 |
|
| 04/04/2023 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Gifted 100,000 shares
@ $0
Granted 500,000 options to buy
@ $9, valued at
$4.5M
|
|
| 02/02/2023 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Paid exercise price by delivering 268,337 shares
@ $8.18, valued at
$2.2M
Exercised 500,000 options to buy
@ $0.6, valued at
$300k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Paid exercise price by delivering 317,291 shares
@ $10.41, valued at
$3.3M
Exercised 600,000 options to buy
@ $0.6, valued at
$360k
|
|
| 08/10/2022 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Paid exercise price by delivering 316,605 shares
@ $10.84, valued at
$3.4M
Exercised 600,000 options to buy
@ $0.6, valued at
$360k
|
|
| 07/05/2022 |
4
| Barr Jason Michael (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12.92, valued at
$516.8k
|
|
| 07/05/2022 |
4
| GLECKEL LOUIS MD (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12.92, valued at
$516.8k
|
|
| 07/05/2022 |
4
| Hirsch Warren (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 40,000 options to buy
@ $12.92, valued at
$516.8k
|
|
| 05/25/2022 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Paid exercise price by delivering 278,257 shares
@ $8.47, valued at
$2.4M
Exercised 450,000 options to buy
@ $2, valued at
$900k
|
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Barr Jason Michael (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Bought 750 shares
@ $6.48, valued at
$4.9k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Barr Jason Michael (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.28, valued at
$528k
|
|
| 06/10/2021 |
4
| GLECKEL LOUIS MD (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.28, valued at
$528k
|
|
| 06/10/2021 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Bought 33,943 shares
@ $5.065, valued at
$171.9k
|
|
| 05/10/2021 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Gifted 120,000 shares
@ $0
Gifted 60,000 shares
@ $0 |
|
| 09/11/2020 |
4
| Hirsch Warren (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.83, valued at
$141.5k
|
|
| 09/11/2020 |
4
| GLECKEL LOUIS MD (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.83, valued at
$283k
|
|
| 09/11/2020 |
4
| Barr Jason Michael (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.83, valued at
$141.5k
|
|
| 08/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2020 |
4
| GLECKEL LOUIS MD (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 6,068 shares
@ $1.85, valued at
$11.2k
|
|
| 04/02/2020 |
4
| Barr Jason Michael (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 3,641 shares
@ $1.85, valued at
$6.7k
|
|
| 03/27/2020 |
4
| GLECKEL LOUIS MD (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Bought 100,000 shares
@ $1.75, valued at
$175k
|
|
| 03/27/2020 |
4
| Karkus Ted William (CEO & CHAIRMAN) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Sold 100,000 shares
@ $1.75, valued at
$175k
|
|
| 01/03/2020 |
4
| Barr Jason Michael (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 2,782 shares
@ $2.02, valued at
$5.6k
|
|
| 01/03/2020 |
4
| GLECKEL LOUIS MD (Director) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 5,564 shares
@ $2.02, valued at
$11.2k
|
|
| 11/22/2019 |
4
| Brady Monica L. (CFO) has filed a Form 4 on ProPhase Labs, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.01, valued at
$201k
|
|
|
|
|